EGElizabeth M. J. Gillam

Elizabeth M. J. Gillam

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elizabeth M. J. Gillam has a total of 442 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Thermostable ancestors enabled evolutionary diversification of promiscuous chemical defence enzymes

    by Raine E S Thomson, Yosephine Gumulya, Anthony W Bengochea, Gabriel Foley, Julian Zaugg, Anna Aagaard, Connie M Ross, James Beckett, Mikael Bodén, Ulrik Jurva, et al.

    Enzymes are generally believed to evolve from promiscuous ancestors to more specialized descendants under some selection pressure related to their function. However, enzymes whose function depends on substrate promiscuity have not been studied. Here, we show that a group of highly diverse, xenobiotic-metabolizing enzymes, responsible for defense against a constantly changing battery of xenobiotic chemicals, evolved from highly thermostable ancestors. Thermostability declined in parallel with the accumulation of sequence diversity through evolution. The major lineages differed in their relative diversification, with the more stable lineage leading to greater extant sequence diversity. Thermostability was associated with a trend towards better sequestration of hydrophobic residues within the core of the protein and increased exposure of polar residues in solvent-accessible parts of the structure. Resurrected ancestral forms were active towards typical substrates and exhibited ligand-binding promiscuity comparable to, or greater than, their extant descendants. This work supports the hypothesis that robust ancestors facilitate evolutionary diversification and highlights features responsible for enhancing thermostability in a protein fold.


  • Solution Architecture of Ancestral Cytochrome P450 Reductase Lipoprotein Nanodiscs

    by Kamila Stokowa-Sołtys, Francisco Zarate-Perez, Wellington Leite, Kevin L. Weiss, Yichi Zhang, Elizabeth M. J. Gillam, John C. Hackett

  • Open Access

    Protein engineering: status report

    by Hui-Wang Ai, Frances H Arnold, Doug Barrick, Hagan Bayley, Alfie-Louise R Brownless, Robert E Campbell, Roger Castells-Graells, Pimchai Chaiyen, Roberto A Chica, Lauren O Chisholm, et al.

    With this status report, we aim to provide a timely snapshot of the protein engineering field as a broad and rapidly advancing discipline that integrates computational, molecular biology, structure-guided, evolutionary, and synthetic approaches to create new and improved proteins with tailored structures and useful functions. The report is organized into eight thematic areas spanning core methodologies and major application domains, including enzymes, therapeutics, detection, synthetic biology, and materials. Contributions from experts across these areas highlight both the historical foundations and recent advances in their respective fields, with particular emphasis on the growing influence of machine learning and artificial intelligence-based methods. Emerging from this broad overview is a central message: protein engineering appears to be entering a golden age, defined by a rapidly accelerating pace of progress, even as significant challenges in design, screening, and real-world application remain. Looking ahead, the continued integration of computational and experimental strategies is poised to further accelerate the impact of protein engineering across an expanding range of economically and societally important sectors, from therapeutics and molecular imaging to diagnostics, plastic recycling, and industrial chemistry.


  • Open Access

    Reconstitution of Human Cytochrome P450 Activity using a Leishmania Cell-Free Protein Expression System

    by Wayne A. Johnston, Raine E. S. Thomson, Juan Alfaro-Palma, Robert E. Speight, Kirill Alexandrov, Elizabeth M. J. Gillam, James B. Y. Behrendorff

    Cytochrome P450 enzymes (P450s) are ubiquitous in drug metabolism and natural product biosynthesis. Studying eukaryotic P450s has been limited by their dependence on membrane association and the requirement for partner reductases. Here, we demonstrate cell-free synthesis and assay of human P450s 3A4 and 2D6 using Leishmania tarentolae translational extract. These P450s were coexpressed with various NADPH-cytochrome P450 reductases (CPRs), and activity was assayed directly using unpurified reactions. P450s 3A4 and 2D6 showed distinct preferences in reductase coupling: P450 3A4 activity was greatest when coupled to the human CPR, whereas P450 2D6 performed better when coexpressed with CPRs from Arabidopsis thaliana. Inhibition assays with chloramphenicol, terbinafine, and erythromycin yielded results consistent with known P450-drug interactions. We conclude that Leishmania-based cell-free protein synthesis resolves previous challenges in eukaryotic P450 expression, allowing for rapid and convenient functional studies of unmodified eukaryotic P450 systems and offering a practical tool for drug metabolism studies and biocatalyst discovery.


  • Open Access

    Exploring extreme environments in Türkiye for novel P450s through metagenomic analysis

    by Hande Mumcu, Julian Zaugg, Irem Keles, Aycan Kayrav, Nurgul Balci, David R. Nelson, Philip Hugenholtz, Elizabeth M. J. Gillam, Nevin Gul Karaguler

    Cytochrome P450 enzymes (P450s), particularly those of microbial origin, are highly versatile biocatalysts capable of catalyzing a broad range of regio- and stere-oselective reactions. P450s derived from extremophiles are of particular interest due to their potential tolerance to high temperature, salinity, and acidity. This study aimed to identify and classify novel microbial P450 enzymes from extreme environments across Türkiye, including hydrothermal springs, hypersaline lakes, and an acid-mine drainage site. The focus of this study was on classifying the sequence diversity of P450 enzymes in these sites. To that end, shotgun metagenomic analysis of six sites, using de novo binning, phylogenetic analysis, and functional gene annotation, was used to discover 311 putative P450 sequences, assigned to 87 families and 158 subfamilies, including 8 novel families and 49 new subfamilies. Of these, 237 were in 138 metagenomic bins, including 45 high-quality metagenome-assembled genomes. The distribution of P450 families varied across sites, reflecting distinct environmental conditions and microbial community compositions. These findings highlight the untapped potential of Türkiye’s extreme habitats as a source of novel biocatalysts. Beyond their industrial relevance, extremophile-derived P450s may also play key roles in enabling microbial adaptation to harsh environmental conditions, through their involvement in stress-responsive metabolic pathways and structurally resilient enzyme forms. This work provides a foundation for future studies into both their biotechnological applications and ecological functions.

  • Open Access

    Reconstitution of human cytochrome P450 activity using a Leishmania cell-free protein expression system

    by Wayne A. Johnston, Raine E. S. Thomson, Juan Alfaro-Palma, Robert E. Speight, Kirill Alexandrov, Elizabeth M. J. Gillam, James B. Y. Behrendorff

    Cytochrome P450 enzymes (P450s) are ubiquitous in drug metabolism and natural product biosynthesis. Studying eukaryotic P450s has been limited by their dependence on membrane association and requirement for partner reductases. Here, we demonstrate cell-free synthesis and assay of human P450s 3A4 and 2D6 using Leishmania tarentolae translational extract. These P450s were co-expressed with various NADPH-cytochrome P450 reductases (CPRs), and activity was assayed directly using unpurified reactions. P450s 3A4 and 2D6 showed distinct preferences in reductase coupling: P450 3A4 activity was greatest when coupled to the human CPR, whereas P450 2D6 performed better when co-expressed with CPRs from Arabidopsis thaliana . Inhibition assays with chloramphenicol, terbinafine, and erythromycin yielded results consistent with known P450-drug interactions. We conclude that Leishmania -based cell-free protein synthesis resolves previous challenges in eukaryotic P450 expression, allowing for rapid and convenient functional studies of unmodified eukaryotic P450 systems, offering a practical tool for drug metabolism studies and biocatalyst discovery.

  • Thermostable fatty acid hydroxylases from ancestral reconstruction of cytochrome P450 family 4 enzymes

    by Kurt L. Harris, Yichi Zhang, Jade Yang, Maxwell B. Zeigler, Raine E. S. Thomson, Saskya E. Carrera-Pacheco, Drake Russell, Shoko Okada, Silja J. Strohmaier, Yosephine Gumulya, et al.

    Biopolymers produced from plant sources offer sustainable alternatives to plastics derived from petrochemicals. Hydroxylated fatty acids (OHFAs) can be readily polymerized to form polyesters. The CYP4 family of cytochrome P450 monooxygenases are potential biocatalysts for fatty acid (FA) ω-hydroxylation, but existing CYP4 enzymes are limited by their inherently low thermostability. Here we resurrected ancestral FA hydroxylases belonging to the CYP4ABTXZ clade, that were significantly more thermostable than the corresponding extant forms with 10T50 values up to 68 °C. All ancestors were active towards C12–C20 FAs, but differed in chain length preference and hydroxylation regioselectivity. While extant CYP4A and CYP4B forms preferentially hydroxylate the terminal (ω) carbon, the ancestors showed less specificity for the ω-position for C12–C18 FAs overall. All ancestors were more active towards arachidonic acid (C20) than the extant forms tested, preferring hydroxylation at the ω-position. Reactions could be made more cost effective by using O2 surrogates, obviating the need for O2, NADPH or a co-expressed redox partner. These enzymes will serve as robust templates for the further engineering of stable FA hydroxlases with activity towards different FAs and alkyl chain positions to produce precursors for synthetic fibres with desired properties.


  • Open Access

    Engineering Biocatalysts for the C−H Activation of Fatty Acids by Ancestral Sequence Reconstruction**

    by Bethan S. Jones, Connie M. Ross, Gabriel Foley, Nadiia Pozhydaieva, Joseph W. Sharratt, Nico Kress, Lisa S. Seibt, Raine E. S. Thomson, Yosephine Gumulya, Martin A. Hayes, et al.

    Selective, one‐step C−H activation of fatty acids from biomass is an attractive concept in sustainable chemistry. Biocatalysis has shown promise for generating high‐value hydroxy acids, but to date enzyme discovery has relied on laborious screening and produced limited hits, which predominantly oxidise the subterminal positions of fatty acids. Herein we show that ancestral sequence reconstruction (ASR) is an effective tool to explore the sequence‐activity landscape of a family of multidomain, self‐sufficient P450 monooxygenases. We resurrected 11 catalytically active CYP116B ancestors, each with a unique regioselectivity fingerprint that varied from subterminal in the older ancestors to mid‐chain in the lineage leading to the extant, P450‐TT. In lineages leading to extant enzymes in thermophiles, thermostability increased from ancestral to extant forms, as expected if thermophily had arisen de novo. Our studies show that ASR can be applied to multidomain enzymes to develop active, self‐sufficient monooxygenases as regioselective biocatalysts for fatty acid hydroxylation.


  • Open Access

    Engineering Biocatalysts for the C−H Activation of Fatty Acids by Ancestral Sequence Reconstruction**

    by Bethan S. Jones, Connie M. Ross, Gabriel Foley, Nadiia Pozhydaieva, Joseph W. Sharratt, Nico Kress, Lisa S. Seibt, Raine E. S. Thomson, Yosephine Gumulya, Martin A. Hayes, et al.

    Selective, one‐step C−H activation of fatty acids from biomass is an attractive concept in sustainable chemistry. Biocatalysis has shown promise for generating high‐value hydroxy acids, but to date enzyme discovery has relied on laborious screening and produced limited hits, which predominantly oxidise the subterminal positions of fatty acids. Herein we show that ancestral sequence reconstruction (ASR) is an effective tool to explore the sequence‐activity landscape of a family of multidomain, self‐sufficient P450 monooxygenases. We resurrected 11 catalytically active CYP116B ancestors, each with a unique regioselectivity fingerprint that varied from subterminal in the older ancestors to mid‐chain in the lineage leading to the extant, P450‐TT. In lineages leading to extant enzymes in thermophiles, thermostability increased from ancestral to extant forms, as expected if thermophily had arisen de novo. Our studies show that ASR can be applied to multidomain enzymes to develop active, self‐sufficient monooxygenases as regioselective biocatalysts for fatty acid hydroxylation.


  • Biocatalysis using Thermostable Cytochrome P450 Enzymes in Bacterial Membranes – Comparison of Metabolic Pathways with Human Liver Microsomes and Recombinant Human Enzymes

    by Ulrik Jurva, Ann-Sofie Sandinge, Jong Min Baek, Mickaël Avanthay, Raine E. S. Thomson, Stephlina A. D’cUnha, Shalini Andersson, Martin A. Hayes, Elizabeth M. J. Gillam

    Detailed structural characterization of small molecule metabolites is desirable during all stages of drug development, and often relies on the synthesis of metabolite standards. However, introducing structural changes into already complex, highly functionalized small molecules both regio- and stereo-selectively can be challenging using purely chemical approaches, introducing delays into the drug pipeline. An alternative is to use the cytochrome P450 enzymes (P450s) that produce the metabolites in vivo, taking advantage of the enzyme’s inherently chiral active site to achieve regio- and stereoselectivity. Importantly, biotransformations are more sustainable: they proceed under mild conditions and avoid environmentally damaging solvents and transition metal catalysts. Recombinant enzymes avoid the need to use animal liver microsomes. However, native enzymes must be stabilized to work for extended periods or at elevated temperatures, and stabilizing mutations can alter catalytic activity. Here we assessed a set of novel, thermostable P450s in bacterial membranes, a format analogous to liver microsomes, for their ability to metabolize drugs through various pathways and compared them to human liver microsomes. Collectively, the thermostable P450s could replicate the metabolic pathways seen with human liver microsomes, including bioactivation to protein-reactive intermediates. Novel metabolites were found, suggesting the possibility of obtaining metabolites not produced by human or rodent liver microsomes. Importantly, no alteration in assay conditions from standard protocols for microsomal incubations was necessary. Thus, such bacterial membranes represent an analogous metabolite generation system to liver microsomes in terms of metabolites produced and ease of use, but which provides access to more diversity of metabolite structures. SIGNIFICANCE STATEMENT In drug development it is often chemically challenging, to synthesize authentic metabolites of drug candidates for structural identification and evaluation of activity and safety. Biosynthesis using microsomes or recombinant human enzymes is confounded by the instability of the enzymes. Here we show that thermostable ancestral cytochrome P450 enzymes derived from P450 families responsible for human drug metabolism offer advantages over the native human forms in being more robust and over microbial enzymes in faithfully reflecting human drug metabolism.